These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36304683)
21. Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Lee CL; Chen WS; Wee Y; Wang CS; Chen WC; Chiu TJ; Wang YM; Wu CN; Yang YH; Luo SD; Wu SC Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158969 [TBL] [Abstract][Full Text] [Related]
22. A Retrospective Review of Upper Gastrointestinal Bleed Outcomes During Hospital Admission While on Oral Anticoagulation. Scibelli N; Mangano A; Raynor K; Wilson S; Singh P Cureus; 2021 May; 13(5):e15061. PubMed ID: 34150404 [TBL] [Abstract][Full Text] [Related]
23. Assessing patient preferences for switching from warfarin to direct oral anticoagulants. Wright JN; Vazquez SR; Kim K; Jones AE; Witt DM J Thromb Thrombolysis; 2019 Nov; 48(4):596-602. PubMed ID: 31273515 [TBL] [Abstract][Full Text] [Related]
24. Enhancement and evaluation of a prescription audit system for direct oral anticoagulants using a check sheet. Ishikawa N; Oshikiri H; Takasaki S; Kikuchi M; Obara T; Akasaka K; Matsuura M; Yamaguchi H; Mano N J Pharm Health Care Sci; 2021 Jun; 7(1):22. PubMed ID: 34059144 [TBL] [Abstract][Full Text] [Related]
25. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries. Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678 [TBL] [Abstract][Full Text] [Related]
26. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant. Wadsworth D; Sullivan E; Jacky T; Sprague T; Feinman H; Kim J J Clin Pharm Ther; 2021 Jun; 46(3):560-570. PubMed ID: 33393699 [TBL] [Abstract][Full Text] [Related]
27. Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants. Mull HJ; Shin MH; Engle RL; Linsky AM; Kalver E; Lamkin R; Sullivan JL Patient Prefer Adherence; 2020; 14():1911-1922. PubMed ID: 33116435 [TBL] [Abstract][Full Text] [Related]
29. The Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting. Yates NY; Hale SA; Clark NP J Pharm Pract; 2024 Jun; 37(3):671-676. PubMed ID: 36989436 [No Abstract] [Full Text] [Related]
30. Anticoagulant Utilization and Direct Oral Anticoagulant Prescribing in Patients with Nonvalvular Atrial Fibrillation. Shum P; Klammer G; Toews D; Barry A Can J Hosp Pharm; 2019; 72(6):428-434. PubMed ID: 31853143 [TBL] [Abstract][Full Text] [Related]
31. Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant. Minhas AS; Jiang Q; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; Froehlich JB; Barnes GD J Thromb Thrombolysis; 2016 Nov; 42(4):566-72. PubMed ID: 27217043 [TBL] [Abstract][Full Text] [Related]
32. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin . Adachi T; Hoshino H; Takagi M; Fujioka S; Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486 [TBL] [Abstract][Full Text] [Related]
33. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Ahmed NO; Osman B; Abdelhai YM; El-Hadiyah TMH Int J Clin Pharm; 2017 Aug; 39(4):769-773. PubMed ID: 28508324 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients. Kalani C; Awudi E; Alexander T; Udeani G; Surani S Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732 [No Abstract] [Full Text] [Related]
35. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar. Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552 [TBL] [Abstract][Full Text] [Related]
36. Impact of a pharmacist intervention on DOAC knowledge and satisfaction in ambulatory patients. Pham T; Patel P; Mbusa D; Kapoor A; Crawford S; Sadiq H; Rampam S; Wagner J; Gurwitz JH; Mazor KM J Thromb Thrombolysis; 2023 Feb; 55(2):346-354. PubMed ID: 36510110 [TBL] [Abstract][Full Text] [Related]
37. High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy. Manzoor BS; Walton SM; Sharp LK; Galanter WL; Lee TA; Nutescu EA J Thromb Thrombolysis; 2017 Nov; 44(4):435-441. PubMed ID: 29027097 [TBL] [Abstract][Full Text] [Related]
38. Direct oral anticoagulant use in left ventricular thrombus. Ali Z; Isom N; Dalia T; Sami F; Mahmood U; Shah Z; Gupta K Thromb J; 2020; 18():29. PubMed ID: 33132763 [TBL] [Abstract][Full Text] [Related]
39. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795 [TBL] [Abstract][Full Text] [Related]
40. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. Poon IO; Lal L; Brown EN; Braun UK J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]